These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 37668317)

  • 1. Gut microbiota from patients with COVID-19 cause alterations in mice that resemble post-COVID symptoms.
    Mendes de Almeida V; Engel DF; Ricci MF; Cruz CS; Lopes ÍS; Alves DA; d' Auriol M; Magalhães J; Machado EC; Rocha VM; Carvalho TG; Lacerda LSB; Pimenta JC; Aganetti M; Zuccoli GS; Smith BJ; Carregari VC; da Silva Rosa E; Galvão I; Dantas Cassali G; Garcia CC; Teixeira MM; André LC; Ribeiro FM; Martins FS; Saia RS; Costa VV; Martins-de-Souza D; Hansbro PM; Marques JT; Aguiar ERGR; Vieira AT
    Gut Microbes; 2023 Dec; 15(2):2249146. PubMed ID: 37668317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of gut microbiota with the pathogenesis of SARS-CoV-2 Infection in people living with HIV.
    Ishizaka A; Koga M; Mizutani T; Yamayoshi S; Iwatsuki-Horimoto K; Adachi E; Suzuki Y; Kawaoka Y; Yotsuyanagi H
    BMC Microbiol; 2024 Jan; 24(1):6. PubMed ID: 38172680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alteration of the gut microbiota following SARS-CoV-2 infection correlates with disease severity in hamsters.
    Sencio V; Machelart A; Robil C; Benech N; Hoffmann E; Galbert C; Deryuter L; Heumel S; Hantute-Ghesquier A; Flourens A; Brodin P; Infanti F; Richard V; Dubuisson J; Grangette C; Sulpice T; Wolowczuk I; Pinet F; Prévot V; Belouzard S; Briand F; Duterque-Coquillaud M; Sokol H; Trottein F
    Gut Microbes; 2022; 14(1):2018900. PubMed ID: 34965194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alterations in Gut Microbiota of Patients With COVID-19 During Time of Hospitalization.
    Zuo T; Zhang F; Lui GCY; Yeoh YK; Li AYL; Zhan H; Wan Y; Chung ACK; Cheung CP; Chen N; Lai CKC; Chen Z; Tso EYK; Fung KSC; Chan V; Ling L; Joynt G; Hui DSC; Chan FKL; Chan PKS; Ng SC
    Gastroenterology; 2020 Sep; 159(3):944-955.e8. PubMed ID: 32442562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolonged Impairment of Short-Chain Fatty Acid and L-Isoleucine Biosynthesis in Gut Microbiome in Patients With COVID-19.
    Zhang F; Wan Y; Zuo T; Yeoh YK; Liu Q; Zhang L; Zhan H; Lu W; Xu W; Lui GCY; Li AYL; Cheung CP; Wong CK; Chan PKS; Chan FKL; Ng SC
    Gastroenterology; 2022 Feb; 162(2):548-561.e4. PubMed ID: 34687739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nutritional Modulation of Gut Microbiota Alleviates Severe Gastrointestinal Symptoms in a Patient with Post-Acute COVID-19 Syndrome.
    Wang Y; Wu G; Zhao L; Wang W
    mBio; 2022 Apr; 13(2):e0380121. PubMed ID: 35254129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alterations of the gut microbiota in coronavirus disease 2019 and its therapeutic potential.
    Xiang H; Liu QP
    World J Gastroenterol; 2022 Dec; 28(47):6689-6701. PubMed ID: 36620345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Signatures of disease outcome severity in the intestinal fungal and bacterial microbiome of COVID-19 patients.
    Rizzello F; Viciani E; Gionchetti P; Filippone E; Imbesi V; Melotti L; Dussias NK; Salice M; Santacroce B; Padella A; Velichevskaya A; Marcante A; Castagnetti A
    Front Cell Infect Microbiol; 2024; 14():1352202. PubMed ID: 38510960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Temporal landscape of human gut RNA and DNA virome in SARS-CoV-2 infection and severity.
    Zuo T; Liu Q; Zhang F; Yeoh YK; Wan Y; Zhan H; Lui GCY; Chen Z; Li AYL; Cheung CP; Chen N; Lv W; Ng RWY; Tso EYK; Fung KSC; Chan V; Ling L; Joynt G; Hui DSC; Chan FKL; Chan PKS; Ng SC
    Microbiome; 2021 Apr; 9(1):91. PubMed ID: 33853691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploring gut-lung axis crosstalk in SARS-CoV-2 infection: Insights from a hACE2 mouse model.
    Zhang Y; Ma Y; Sun W; Zhou X; Wang R; Xie P; Dai L; Gao Y; Li J
    J Med Virol; 2024 Jan; 96(1):e29336. PubMed ID: 38193530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
    Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
    Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Respiratory dysfunction three months after severe COVID-19 is associated with gut microbiota alterations.
    Vestad B; Ueland T; Lerum TV; Dahl TB; Holm K; Barratt-Due A; Kåsine T; Dyrhol-Riise AM; Stiksrud B; Tonby K; Hoel H; Olsen IC; Henriksen KN; Tveita A; Manotheepan R; Haugli M; Eiken R; Berg Å; Halvorsen B; Lekva T; Ranheim T; Michelsen AE; Kildal AB; Johannessen A; Thoresen L; Skudal H; Kittang BR; Olsen RB; Ystrøm CM; Skei NV; Hannula R; Aballi S; Kvåle R; Skjønsberg OH; Aukrust P; Hov JR; Trøseid M;
    J Intern Med; 2022 Jun; 291(6):801-812. PubMed ID: 35212063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of microbiota in the gut and upper respiratory tract associated with SARS-CoV-2 infection.
    Li J; Jing Q; Li J; Hua M; Di L; Song C; Huang Y; Wang J; Chen C; Wu AR
    Microbiome; 2023 Mar; 11(1):38. PubMed ID: 36869345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Profiles of gut microbiota associated with clinical outcomes in patients with different stages of SARS-CoV-2 infection.
    Krasaewes K; Chaiwarith R; Chattipakorn N; Chattipakorn SC
    Life Sci; 2023 Nov; 332():122136. PubMed ID: 37783267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mild SARS-CoV-2 infection results in long-lasting microbiota instability.
    Upadhyay V; Suryawanshi RK; Tasoff P; McCavitt-Malvido M; Kumar RG; Murray VW; Noecker C; Bisanz JE; Hswen Y; Ha CWY; Sreekumar B; Chen IP; Lynch SV; Ott M; Lee S; Turnbaugh PJ
    mBio; 2023 Aug; 14(4):e0088923. PubMed ID: 37294090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SARS-CoV-2 infection in nonhuman primates alters the composition and functional activity of the gut microbiota.
    Sokol H; Contreras V; Maisonnasse P; Desmons A; Delache B; Sencio V; Machelart A; Brisebarre A; Humbert L; Deryuter L; Gauliard E; Heumel S; Rainteau D; Dereuddre-Bosquet N; Menu E; Ho Tsong Fang R; Lamaziere A; Brot L; Wahl C; Oeuvray C; Rolhion N; Van Der Werf S; Ferreira S; Le Grand R; Trottein F
    Gut Microbes; 2021; 13(1):1-19. PubMed ID: 33685349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gut microbiota in COVID-19: key microbial changes, potential mechanisms and clinical applications.
    Zhang F; Lau RI; Liu Q; Su Q; Chan FKL; Ng SC
    Nat Rev Gastroenterol Hepatol; 2023 May; 20(5):323-337. PubMed ID: 36271144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coronavirus Disease (COVID-19) Caused by (SARS-CoV-2) Infections: A Real Challenge for Human Gut Microbiota.
    Vodnar DC; Mitrea L; Teleky BE; Szabo K; Călinoiu LF; Nemeş SA; Martău GA
    Front Cell Infect Microbiol; 2020; 10():575559. PubMed ID: 33363049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COVID-19 - gastrointestinal and gut microbiota-related aspects.
    Kaźmierczak-Siedlecka K; Vitale E; Makarewicz W
    Eur Rev Med Pharmacol Sci; 2020 Oct; 24(20):10853-10859. PubMed ID: 33155247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The relationship between gut microbiota and COVID-19 progression: new insights into immunopathogenesis and treatment.
    Wang M; Zhang Y; Li C; Chang W; Zhang L
    Front Immunol; 2023; 14():1180336. PubMed ID: 37205106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.